Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Issue of Equity

10 Feb 2014 07:00

RNS Number : 6237Z
First Derivatives PLC
10 February 2014
 

 10th February 2014

 

First Derivatives plc

("First Derivatives" or the "Company")

 

Dealing by Director

Exercise of Options

 

First Derivatives (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services to the capital markets industry, is pleased to announce that, following the exercise of options by a Director and certain employees, 179,167 new ordinary shares of 0.5p each in the Company have been issued and allotted.

 

Accordingly, application has been made for the 179,167 new ordinary shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 13th February 2014.

 

This includes options over 10,000 new ordinary shares exercised by Mr David Anderson, a Non-Executive Director, at a price of 178.5 pence per ordinary share.

 

Following this transaction Mr Anderson retains a holding of 142,500 First Derivatives ordinary shares representing approximately 0.73 per cent. of the issued share capital of the Company. Mr Anderson also has a beneficial interest in share options over 50,000 First Derivatives ordinary shares which represent approximately 0.25 per cent. of the issued share capital of the Company.

 

The new ordinary shares will rank pari passu with the existing shares of the Company. Following this allotment, the total issued share capital of the Company will increase to 19,485,988 ordinary shares.

 

Enquiries:

 

First Derivatives plc

+44(0)28 3025 2242

Brian Conlon, Chief Executive Officer

www.firstderivatives.com

Graham Ferguson, Finance Director

Charles Stanley Securities

+44 (0)20 7149 6000

(Nominated Adviser& Broker)

Russell Cook

Carl Holmes

GoodbodyCorporate Finance

+353 1 667 0420

(ESM Adviser)

Finbarr Griffin

Goodbody Stockbrokers

Linda Hickey

 

Walbrook PR

+44 (0)20 7933 8780

Financial PR

bob.huxford@walbrookpr.com

Bob Huxford

helen.westaway@walbrookpr.com

Helen Westaway

 

About First Derivatives

 

First Derivatives is a global provider of software and consulting services to the financial services industry. With almost 17 years' experience working with leading financial institutions, it continues to deliver technologically advanced products and services that anticipate and respond to the evolving needs of global capital markets.

 

First Derivatives currently employs over 850 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It has operations in London, New York, Stockholm, Shanghai, Singapore, Toronto, Sydney, Dublin, Newry and Hong Kong.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEQKODPABKDQBK
Date   Source Headline
30th Sep 20191:20 pmRNSTotal Voting Rights
9th Sep 20197:00 amRNSEuronext Growth Dublin Notice
3rd Sep 20194:09 pmRNSIssue of Equity
2nd Sep 20194:35 pmRNSHolding(s) in Company
1st Aug 20198:01 amRNSTotal Voting Rights
1st Aug 20197:00 amRNSEuronext Growth Dublin Notice
31st Jul 20197:38 amRNSHolding(s) in Company
29th Jul 20197:00 amRNSStatement regarding Brian Conlon
26th Jul 20193:24 pmRNSIssue of Equity
19th Jul 201912:00 pmRNSHolding(s) in Company
9th Jul 20198:03 amRNSAdmission of Shares
9th Jul 20197:00 amRNSEuronext Growth Dublin Notice
8th Jul 20194:31 pmRNSHolding(s) in Company
5th Jul 20195:31 pmRNSHolding(s) in Company
3rd Jul 20197:00 amRNSIssue of Equity
2nd Jul 20195:42 pmRNSProposed Secondary Placing
28th Jun 20191:10 pmRNSHolding(s) in Company
27th Jun 20193:48 pmRNSAGM Statement
18th Jun 20197:00 amRNSAcquisition of minority interest in Kx Systems
4th Jun 20194:11 pmRNSNotice of AGM
31st May 20193:35 pmRNSTotal Voting Rights
31st May 20197:00 amRNSEuronext Growth Dublin Notice
24th May 20196:19 pmRNSIssue of Equity
21st May 20197:00 amRNSFull year results for the year ended 28 Feb 2019
17th May 20197:00 amRNSStatement regarding Brian Conlon
18th Apr 20197:00 amRNSTrading Statement and Notice of Results
29th Mar 20192:29 pmRNSTotal Voting Rights
20th Mar 20197:00 amRNSEuronext Growth Dublin Notice
13th Mar 20194:52 pmRNSIssue of Equity
12th Feb 20194:05 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSCapital Markets Day
6th Feb 20197:00 amRNSExtended Bank Facilities on Improved Terms
31st Jan 201911:00 amRNSTotal Voting Rights
9th Jan 20197:00 amRNSNotice of Capital Markets Day
21st Dec 20185:07 pmRNSIssue of Equity
6th Nov 20187:00 amRNSInterim Results
17th Oct 20187:00 amRNSOEM agreement with BISTel
11th Oct 20187:00 amRNSNotice of Results
28th Sep 20183:31 pmRNSTotal Voting Rights
7th Sep 20188:00 amRNSEnterprise Securities Market Notice
31st Aug 20183:26 pmRNSIssue of Equity
31st Aug 20189:03 amRNSTotal Voting Rights
10th Aug 20187:00 amRNSEnterprise Securities Market Notice
3rd Aug 20184:14 pmRNSIssue of Equity
31st Jul 201811:07 amRNSTotal Voting Rights
31st Jul 201811:02 amRNSTotal Voting Rights
16th Jul 20187:00 amRNSEuropean Energy Market Contract Win
12th Jul 20187:00 amRNSEnterprise Securities Market Notice
9th Jul 20185:50 pmRNSHolding(s) in Company
6th Jul 20185:03 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.